European Pharmaceutical Review delivers current news and statistics on all aspects of drug analysis, formulation, delivery, manufacturing, and regulation. With over two decades of experience, they have established valuable connections with well-known leaders in the life science sector. European Pharmaceutical Review is typically sent to senior professionals in drug discovery, delivery, and distribution services across both Europe and the US.
George I’ons, the Head of Product Strategy and Insights at Owen Mumford Pharmaceutical Services, has once again authored a highly informative and engaging article. In this piece, George explains how pharmaceutical companies can promote the adoption of injectable biosimilars, especially as a way to compete against reference biologics. As patents on top biologics begin to expire, gaining a position in this highly competitive field is increasingly important, so keep reading to discover ways to take your injectable biosimilar to the next level.